Traumix BT

Triple-Action Protection: Optimizing Cereal Health with Traumix BT

For intensive cereal production, single-component fungicides often fail to manage complex infection cycles. Traumix BT leverages a potent combination of thiophanate-methyl, tebuconazole, and epoxiconazole to deliver comprehensive systemic protection. This formulation is tailored for growers aiming to protect the yield potential of winter wheat and barley against the most aggressive fungal threats.

Application and Field Scenarios

Traumix BT is designed to tackle pathogens that frequently cause 30–50% yield losses. It is highly effective in controlling:

• Leaf diseases: powdery mildew, septoria, and scald (rhynchosporium).
• Barley-specific threats: net blotch and helminthosporiosis.
• Stem and root stressors: cercosporella and Fusarium head blight.

Agronomists typically incorporate Traumix BT into their spraying schedules during periods of rapid crop growth. Its systemic action allows for quick penetration and distribution within the plant, providing coverage even for plant tissues not directly hit by the spray. This ensures that the crop remains protected as it develops, even when environmental conditions favor fungal spread.

Technical Efficiency and Usage Guidelines

Presented as a suspension concentrate, Traumix BT offers excellent stability and rapid absorption into leaf tissue. With an application rate of 0.5–0.7 liters per hectare, it provides a precise, cost-effective defense. A maximum of two applications per season is permitted, making it a reliable choice for managing infection pressure throughout the growth cycle.

To ensure high quality and safety, it is critical to adhere to the 30-day pre-harvest interval (PHI). This interval ensures minimal residues, meeting strict industry standards for grain quality. For farms focusing on maximizing profitability, Traumix BT serves as a cornerstone of an effective disease management strategy, securing the crop from early development stages through to heading.